Tadamichi Denda
Tadamichi Denda publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Cancer Research, on topics such as Colorectal Cancer Treatments and Studies, Cancer Genomics and Diagnostics and Cancer Treatment and Pharmacology.
- World rank
- #1,753,507 of 7,710,434 ranked researchers
- Rank in Japan
- #29,957 of 383,136
- Works
- 280
- Citations
- 3.5k
- Citations per work
- 12.7
What does Tadamichi Denda research?
Tadamichi Denda's work is mostly in Medicine (74%), Biochemistry, Genetics and Molecular Biology (15%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences20774.0%
- Medicine20774.0%
- Life Sciences4114.6%
- Everything else3211.4%
- 1Oncology46% of their works
- 2Pulmonary and Respiratory Medicine17% of their works
- 3Cancer Research10% of their works
- 4Pathology and Forensic Medicine7% of their works
- 5Molecular Biology5% of their works
- 6Surgery5% of their works
Research topics
Which keywords describe Tadamichi Denda's research?
The keywords of their largest research topics: Chemotherapy, Cetuximab, KRAS Mutations, Targeted Therapy, Molecular Characterization, Clinical Practice Guidelines, Adjuvant Chemotherapy and Cancer Genomics.
- Hepatocellular Carcinoma
- Preoperative Chemoradiotherapy
- Hereditary Syndromes
- ALK Inhibitors
- Gastric Cancer
- Chemotherapy-Induced Peripheral Neuropathy
- Cancer Genomics
- Clinical Practice Guidelines
- Targeted Therapy
- Cetuximab
- Chemotherapy
- KRAS Mutations
- Molecular Characterization
- Adjuvant Chemotherapy
- Mutational Signatures
- Endoscopic Resection
- Taxanes
- EGFR Mutations
- Microsatellite Instability
- Rectal Cancer
- Liver Cancer
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Chemotherapy2482 topics
- Cetuximab1891 topic
- KRAS Mutations1891 topic
- Targeted Therapy1112 topics
- Molecular Characterization1062 topics
- Clinical Practice Guidelines1053 topics
- Adjuvant Chemotherapy762 topics
- Cancer Genomics631 topic
- Mutational Signatures631 topic
- Chemotherapy-Induced Peripheral Neuropathy591 topic
- Endoscopic Resection591 topic
- Gastric Cancer591 topic
- Taxanes591 topic
- ALK Inhibitors481 topic
- EGFR Mutations481 topic
- Hereditary Syndromes471 topic
- Microsatellite Instability471 topic
- Preoperative Chemoradiotherapy291 topic
- Rectal Cancer291 topic
- Hepatocellular Carcinoma171 topic
- Liver Cancer171 topic
Where does Tadamichi Denda work?
Tadamichi Denda's main affiliation in the publication record is Chiba Cancer Center, Japan.
How many publications and citations does Tadamichi Denda have?
OpenAlex counts 280 works and 3,549 citations for Tadamichi Denda, an h-index of 29, ranking #1,753,507 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Tadamichi Denda. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.